More News

14 Mar 2017 New Survey Reveals Impact Of Double Chin On Self-Perception And Behavior
14 Mar 2017 CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte
14 Mar 2017 AMO Pharma Enters into Collaboration Agreement with Ranedis Pharmaceuticals for Development of RND-001
14 Mar 2017 Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin®
13 Mar 2017 Daiichi Sankyo Enters Agreement with Heptares Therapeutics to Discover and Develop Novel, Small-Molecules for the Treatment of Pain
07 Mar 2017 Cyclenium Pharma Announces a Research Collaboration with The Hospital for Sick Children to Identify Novel Macrocyclic Modulators for Pharmacological Targets in Multiple Therapeutic Areas
07 Mar 2017 Staten Biotechnology exercises option to develop therapeutic SIMPLE AntibodyTM for dyslipidemia from argenx N.V.
07 Mar 2017 Vertex to Acquire CTP-656 from Concert Pharmaceuticals for the Treatment of Cystic Fibrosis
03 Mar 2017 NEMUS Bioscience and Catalent to Advance NB1222 into Human Dosage Formulation Development
03 Mar 2017 Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers
03 Mar 2017 Otsuka Pharmaceutical to Acquire Neurovance, Inc.
03 Mar 2017 MedImmune and Sanofi Pasteur form alliance to develop and commercialise potential next-generation respiratory syncytial virus antibody MEDI8897
02 Mar 2017 Synthon enters worldwide exclusive license and collaboration with Sanquin for immuno-oncology therapeutic leads modulating the CD47-SIRPα pathway
01 Mar 2017 Invenra and QIMR Berghofer Medical Research Institute Enter Collaboration to Discover Therapeutic Antibodies Against Novel Target
28 Feb 2017 Exelixis Announces Clinical Trial Collaboration with Roche to Evaluate Cabozantinib and Atezolizumab in Locally Advanced or Metastatic Solid Tumors
28 Feb 2017 Helix BioPharma Corp. Announces Licence for Worldwide Right to Anti-CEACAM6 Antibody From the Government of Canada
28 Feb 2017 Advaxis and SELLAS Announce Licensing Agreement for Development of WT1 Antigen-Targeting Immunotherapy
28 Feb 2017 Pieris Signs 1st Partnership for Anemia Drug PRS-080, Granting Exclusive Option in Japan to ASKA Pharmaceutical
28 Feb 2017 Bushu and Takeda Announce Transformational Pharmaceutical Sciences Partnership
27 Feb 2017 Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility
27 Feb 2017 MolMed and Rocket Pharma establish a collaboration agreement in the field of gene therapy for the treatment of Fanconi Anemia
23 Feb 2017 Finch Therapeutics Announces Strategic Collaboration with OpenBiome to Develop Microbiome Therapies for FDA Approval
23 Feb 2017 Incyte Announces Oncology Research Alliance with the Abramson Cancer Center at the University of Pennsylvania
17 Feb 2017 Amygdala Neurosciences Acquires GS-6637 from Gilead Sciences
15 Feb 2017 Signum Biosciences Receives $3.0M Phase IIB SBIR Grant for the Development of SIG1451, A Novel Therapeutic for Atopic Dermatitis

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing